Immunoprofiling in alveolar soft part sarcoma.
Samer Salah(Roche (Switzerland)), Albiruni Ryan Abdul Razak(Roche (Switzerland)), Peter C. Ferguson(University of Toronto), Jeremy Lewin(Mount Sinai Hospital), Adam Shlien(Hospital for Sick Children), Jay S. Wunder(Sinai Health System), Brendan C. Dickson(Sinai Health System), Nathaniel D. Anderson(Wellcome Sanger Institute), Sergio L Periera(Hospital for Sick Children), Beatrice Y. Lau(Mount Sinai Hospital), Scott Davidson(Hospital for Sick Children)
Cited by 6
Related Papers
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
The Life History of 21 Breast Cancers
|Cell|2012|1.5k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
|Journal of Clinical Oncology|2016|867